GlassScriptPhysician profile
Helen M Blake
NPI 1245438597
$48,282.50
in general payments reported to CMS, 2019-2025
32 companies · $2,922 in 2025
The $2,922 reported for 2025 was more than what 85% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,169 · 2020: $1,053 · 2021: $14K · 2022: $4,481 · 2023: $10K · 2024: $8,552 · 2025: $2,922.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,700 · Food and Beverage: $5,787 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,775 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,948 · Travel and Lodging: $608 · Education: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,700.00 |
| Food and Beverage | $5,787.11 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,775.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,947.50 |
| Travel and Lodging | $608.14 |
| Education | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $18,836.60 | 2019-2025 | Proclaim, Eterna |
| Axogen | $10,836.55 | 2019-2023 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Stratus Medical, LLC | $10,142.83 | 2021-2025 | Nimbus |
| Saluda Medical Americas, INC. | $4,147.36 | 2022-2025 | Evoke Scs, Evoke |
| Medtronic, INC. | $766.88 | 2022-2025 | Intellis Adaptivestim |
| Nevro Corp. | $679.68 | 2019-2023 | Senza |
| Spr Therapeutics, INC | $643.45 | 2021-2025 | Sprint Pns System |
| Stimwave Technologies Incorporated | $402.16 | 2019-2022 | |
| Medtronic USA, INC. | $343.03 | 2019-2020 | |
| Foundation Fusion Solutions, LLC | $266.99 | 2025 | |
| Mml US, INC. | $186.39 | 2023-2024 | Reactiv8 |
| Si-Bone, INC. | $180.07 | 2024-2025 | |
| Vertos Medical, INC. | $152.83 | 2023 | Mild Device Kit |
| Electronic Waveform Lab, INC. | $151.51 | 2019-2024 | |
| Scilex Pharmaceuticals INC. | $149.16 | 2019-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $58.93 | 2020 | |
| Novartis Pharmaceuticals Corporation | $38.16 | 2019-2020 | |
| Pacira Therapeutics, INC. | $32.79 | 2019 | |
| Collegium Pharmaceutical, INC. | $32.69 | 2019 | |
| Horizon Therapeutics Plc | $31.57 | 2019-2022 | |
| Bioventus LLC | $23.83 | 2020 | |
| Stryker Corporation | $22.21 | 2019 | |
| Pacira Cryotech Incorporated | $22.20 | 2019 | |
| Tersera Therapeutics LLC | $22.14 | 2020 | |
| Amgen INC. | $20.71 | 2021 | |
| Abbvie INC. | $16.52 | 2022 | |
| Pfizer INC. | $14.99 | 2019 | |
| Trevena, INC. | $12.42 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $12.24 | 2019 | |
| Shionogi INC | $12.21 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.99 | 2019 | |
| Allergan, INC. | $11.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Helen Blake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.